Skip to main content

Table 1 Demographic and clinicopathological factors in patients with and without sarcopenia who underwent pancreaticoduodenectomy

From: Radiographic sarcopenia predicts postoperative infectious complications in patients undergoing pancreaticoduodenectomy

 

All patients

(n = 219)

Non-sarcopenia

(n = 164)

Sarcopenia

(n = 55)

P-value

Demographic variables

 Sex (men)

143 (65.3)

107 (65.2)

36 (65.5)

0.98

 Age (years)

65.9 (11.7)

65.1 (12.4)

68.2 (9.2)

0.18

 BMI (kg/m2)

21.9 (3.3)

22.0 (3.4)

21.7 (3.0)

0.67

ASA physical status

 1–2/3

203/16

154/10

49/6

0.25

Laboratory value

 Albumin (g/dL)

4.0 (0.5)

4.1 (0.4)

3.9 (0.6)

0.006

 Total lymphocyte (/mm3)

1642 (554)

1665 (561)

1572 (521)

0.30

Child–Pugh score

 A/B

205/14

155/9

50/5

0.36

Comorbidities

 Hypertension

89 (40.6)

68 (41.5)

21 (38.2)

0.67

 Diabetes

64 (29.2)

43 (26.2)

21 (38.2)

0.10

Etiology of the disease

 Pancreatic adenocarcinoma

86 (39.3)

61 (37.2)

25 (45.5)

0.31

 Bile duct carcinoma

27 (12.3)

20 (12.2)

7 (12.7)

 

 Ampullary adenocarcinoma

28 (12.8)

18 (11.0)

10 (18.2)

 

 Duodenal adenocarcinoma

10 (4.6)

9 (5.5)

1 (1.8)

 

 IPMN

32 (14.6)

26 (15.9)

6 (10.9)

 

 Others

36 (16.4)

30 (18.3)

6 (10.9)

 

 Preoperative biliary drainage

101 (46.1)

68 (41.5)

33 (60.0)

0.02

Intraoperative factor

 Operative time (min)

448 (93)

445 (93)

454 (94)

0.64

 Blood loss (mL)

563 (486)

543 (443)

624 (596)

0.96

 Vascular reconstruction

50 (22.8)

37 (22.6)

13 (23.6)

0.87

 Soft pancreatic texture

133 (60.7)

101 (61.6)

32 (58.2)

0.66

 Normal pancreatic duct (< 3 mm)

87 (39.7)

69 (42.1)

18 (32.7)

0.22

  1. Data are presented as numbers (percentages) or means (± standard deviation).
  2. BMI body mass index, ASA American Society of Anesthesiologists, IPMN intraductal papillary mucinous neoplasm